Focuses on the subject of bioethics reforms for participants in clinical trials in the U.S. Efforts of Office for Human Research Protections director Greg Koski in endorsing the reforms; Responsibility of members of institutional review boards; Impact of reform measures on clinical research conducted outside the U.S.